Knowles (KN) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 revenue rose to $143 million, up 32% year-over-year, driven by the Cornell acquisition and 4% organic growth.
Non-GAAP diluted EPS increased 30% to $0.26, at the midpoint of guidance.
Net cash from operations was $53 million, exceeding guidance.
Signed agreement to sell Consumer MEMS Microphones business, advancing shift to higher-growth, higher-margin markets; closing expected late Q4 2024.
Net earnings from continuing operations were $9.2 million, down from $15.2 million in Q3 2023, due to higher expenses and interest.
Financial highlights
Q3 2024 gross margin was 44.1%–45.5%, down year-over-year due to product mix and acquisitions.
Adjusted EBITDA margin was 24.6%; adjusted EBIT margin was 21.1%.
Adjusted EBITDA was $35.0 million, up from $29.1 million year-over-year.
Cash from operations was $53 million in Q3 and $95 million for the first nine months.
Net debt at quarter-end was $132.4 million; net leverage ratio was 1x trailing twelve months adjusted EBITDA.
Outlook and guidance
Q4 2024 revenue expected between $141 million and $151 million, with non-GAAP diluted EPS guidance of $0.14–$0.30.
Net cash from operations projected at $30–$40 million; capital spending at $6 million.
Effective tax rate for Q4 projected at 9%–13% due to foreign tax credits.
Sequential revenue growth anticipated in MedTech & Specialty Audio and Precision Devices segments.
Latest events from Knowles
- Annual meeting covers director elections, executive pay, and auditor ratification for 2026.KN
Proxy Filing11 Mar 2026 - 2026 proxy covers director elections, executive pay, auditor ratification, and robust governance.KN
Proxy Filing11 Mar 2026 - Clean energy and climate/sustainability drive growth as portfolio streamlining boosts margins.KN
Barclays 43rd Annual Industrial Select Conference17 Feb 2026 - Q4 2025 revenue and EPS surged, capping a successful transformation and strong 2026 outlook.KN
Q4 20255 Feb 2026 - Portfolio shift to MedTech, defense, and industrial boosts margins and growth outlook.KN
2024 Southwest IDEAS Conference3 Feb 2026 - Targets 8–10% annual revenue growth and 10–14% EBITDA growth through organic and M&A strategies.KN
Investor Day 20253 Feb 2026 - Q2 revenue up 18.3% to $204.7M; $249.4M goodwill impairment drove $259M net loss.KN
Q2 20242 Feb 2026 - Q1 2025 revenue hit $132.2M, with strong cash flow and robust Precision Devices demand.KN
Q1 202526 Dec 2025 - 2024 revenue up 21% and non-GAAP EPS up 32%, with strong cash flow and major new orders.KN
Q4 202423 Dec 2025